Identifying disease genes is very important not only for better understanding of gene function and biological process but also for human medical improvement. Many computational methods have been proposed based on the similarity between all known disease genes (seed genes) and candidate genes in the entire gene interaction network. Under the hypothesis that potential disease-related genes should be near the seed genes in the network and only the seed genes that are located in the same module with the candidate genes will contribute to disease genes prediction, three modularized candidate disease gene prioritization algorithms (MCDGPAs) are proposed to identify disease-related genes. MCDGPA is divided into three steps: module partition, genes prioritization in each disease-associated module, and rank fusion for the global ranking. When applied to the prostate cancer and breast cancer network, MCDGPA significantly improves previous algorithms in terms of cross-validation and disease-related genes prediction. In addition, the improvement is robust to the selection of gene prioritization methods when implementing prioritization in each disease-associated module and module partition algorithms when implementing network partition. In this sense MCDGPA is a general framework that allows integrating many previous gene prioritization methods and improving predictive accuracy.
Introduction
I dentifying disease genes is very important not only for better understanding of gene function and biological process but also for human medical improvement. Revealing the genetic basis of human disease is a fundamental aim of the human genetic studies (Botstein and Risch, 2003; Brunner and van Driel, 2004) . The genomic regions identified by linkage analysis often exceed 30 centimorgans in size and can contain hundreds of genes (Adie et al., 2005) . The identification of the mutation responsible for the phenotype is still a timeconsuming and expensive task (Botstein et al., 1980; Glazier et al., 2002) . Many Online Mendelian Inheritance in Man (OMIM) entries for phenotypes with unknown molecular basis have at least one associated disease locus, which shows prioritizing genes within these intervals is a formidable challenge (Ala et al., 2008) .
Since the Human Genomic Project started in 1990, the molecular bases of 2,514 phenotype descriptions have been clarified, but still 1,743 Mendelian phenotypes unknown (Hamosh et al., 2005) . The large-scale genomic studies have led to vast amount of biological data that will deepen our insight into the molecular bases of most common diseases. The need to mine, visualize, and integrate these data has motivated the development of computational methods in translational bioinformatics (Kann, 2010) . The integration of experimental techniques and translational bioinformatics has changed the way disease genes are identified. Bioinformatics has been an important part of the search for disease-related genes (Kann, 2010) . Many computational methods have been proposed using gene-expression data, functional annotation information, sequence-based features, and protein-protein interaction data (Adie et al., 2005 (Adie et al., , 2006 Aerts et al., 2006; Franke et al., 2006; Kö hler et al., 2008; Tiffin et al., 2005; Wu et al., 2008) . Many of them are based on the concept of similarity, that is, phenotypically similar diseases are often caused by functionally related genes. This is also referred as the modular nature of human genetic disease (Oti and Brunner, 2007; Van Driel et al., 2006) . Based on this insight, many methods rank genes by computing the similarity between candidate genes and the known disease genes (seed genes) in the entire network. ENDEAVOUR is one of the best gene prioritization methods (Aerts et al., 2006 ) based on similarity between candidate genes and seed genes. It first generates distinct prioritization list of candidate genes for each data source and then fuses each of these rankings from the separate data source into a single ranking. Up to now the method has incorporated more than 10 types of genomic data. Franke et al. 1 (2006) constructed a functional human gene network that integrated information on genes and the functional relationships between them. Then this network is used to rank genes based on their functional interactions. Kö hler et al. (2008) used the global network distance measure, random walk with restart (RWR), and diffusion kernel (DK), instead of simple direct neighborhood and shortest path measure to prioritize candidate disease genes. Another method called CIPHER has integrated human protein-protein interactions, disease phenotype similarities, and known gene-phenotype associations to uncover the relation between phenotype and genotype (Wu et al., 2008) . Human disease genes were also predicted based on conserved co-expression analysis and modular nature (Ala et al., 2008; Oti et al., 2008) .
Based on the modular nature of human genetic diseases, causal genes of the same disease tend to lie close to each other in the network and often share annotations and other characteristics. Furthermore, genes involved in the same disease have been found to form several subnetworks (Gandhi et al., 2006) . In many cases, mutations at different loci could cause the same disease, which reflects an underlying molecular mechanism that disease genes may be located in different modules in the network (Lage et al., 2007; Vanunu et al., 2010; Wu et al., 2009) . In this article, we have investigated the hypothesis that discovering new potential disease-related genes in the disease-associated modules (modules containing seed genes) and using only the known disease genes that are located in the same module with the candidate genes to implement the gene prioritization would benefit the performance of prediction. The concept of module can be either a protein complex (Lage et al., 2007) , a pathway (Wood et al., 2007) , a subnetwork of protein interactions (Lim et al., 2006) , or the cluster (community) in the network clustering (Fortunato et al., 2007; Lancichinetti et al., 2009) . In this article we define the module as the cluster in the network clustering research. Clusters are groups of vertices that probably share common properties and/or play similar roles within the network. So, clusters may be groups of pages of the World Wide Web or functional modules such as cycles and pathways in metabolic networks or groups of related individuals in social networks or compartments in food webs and so on (Fortunato et al., 2007) . Disease genes may have different function and play different roles in the formation of complex diseases, which implies that all the disease genes may be located in different modules. Finding the modules that are associated with disease can help understand the disease mechanism, the identification of disease genes, and the classification of disease (Kann, 2010; Oti and Brunner, 2007) . When similarities between candidate disease genes and seed genes are used to identify potential new disease genes, some candidate genes that are relevant to the disease may not get high similarity score when seed genes are not in the same module with them. Hence, when disease genes are located in different modules, it is very important to partition the network into different modules and rank candidate genes using only seed genes located in the same module with them. Even if all the known disease genes are located in the same module, partitioning all the genes in the network into several modules will identify the module that contains all the known disease genes. As a result, the scope of searching for new potential disease genes is narrowed down and the prediction accuracy may be improved.
Based on forementioned idea, we proposed three modularized candidate disease genes prioritization algorithms (MCDGPAs): modularized ENDEAVOUR (MENDEAVOUR), modularized random walk with restart (MRWR), and modularized diffusion kernel (MDK). First, diseasespecific network is partitioned into several modules, then candidate genes are prioritized in each disease-associated module, and finally, the gene ranking in each disease-associated module is fused into a global ranking in the entire network. We demonstrate that MCDGPA is greatly superior to previous similarity-based methods. For example, in the prostate cancer network, known seed genes are located in different modules. Twenty-nine out of the top 50 genes ranked by MRWR are confirmed by the Prostate Gene DataBase (PDGB) , Kyoto Encyclopedia of Genes and Genomes (KEGG) (Kanehisa et al., 2004) , or the literature. In contrast, classical RWR can only identify 22 disease-related genes. Corresponding to ENDEAVOUR (Aerts et al., 2006) and DK (Kö hler et al., 2008) , MENDEAVOUR and MDK also obtain a great improvement in the prediction. Not only do we try different gene prioritization methods when implementing genes prioritization in the each module, but we also use different module partition algorithms when implementing the network partition. The results show that the performance improvement by our modularized gene prioritization method is not sensitive to the selection of module partition algorithms. MCDGPA also improves the performance of classical algorithms in terms of cross-validation and potential diseaserelated genes prediction when the validation from literature is excluded. For the breast cancer network, the known seed genes are located in the same module. In this case, MCDGPA also can get the improvement on classical algorithms. So we can reach a conclusion that similarity-based disease prioritization algorithm followed by module partition, gene prioritization in the each module, and rank fusion may get much improvement. Hence, MCDGPA is a general framework that allows integration and improvement of many previous gene prioritization methods.
Materials and Methods

Materials
MCDGPA is applied to identify prostate and breast cancer genes. For the prostate cancer, the network contains 233 genes and 1,240 interactions. Our prostate cancer network is generated based on the network in Ozgur's article (Ozgur et al., 2008) , which is constructed by starting with an initial list of 15 prostate cancer seed genes from the Morbid Map component in the OMIM database. Then Gene names tagged by the Genia Tagger (Tsuruoka et al., 2005) are normalized based on the HUGO Gene Nomenclature Committee (HGNC) database (Wain et al., 2007) . Finally, the gene interaction network is built by automatic literature mining based on dependency parsing and a Support Vector Machine with a dependency path edit kernel. This method of constructing disease-specific network utilizes the information hidden in the unstructured text of biomedical articles. Because another two disease genes (ZFHX3 and HNF1B) have been added to OMIM later, we have included these two disease genes and those genes that interact with them in Biological General Repository for Interaction Datasets (Stark et al., 2006) into our network. The interactions between 338 CHEN ET AL.
added genes and previous genes are also considered. Seventeen known genes confirmed by the Morbid Map component of the OMIM database are used as seed genes for our potential disease-related genes prediction. The non-OMIM genes in the network are used as candidate genes. Table 1 lists the seed genes for prostate cancer. The breast cancer network consists of 118 gene and 866 potential functional associations (Pujana et al., 2007) . The dataset is assembled by integrating co-expression profiles in human tissues and functional associations derived from various functional genomic and proteomic data. Hence, models of macromolecular networks that are possibly perturbed in human cancer are generated. In this network, genes confirmed by OMIM are chosen as seed genes for our potential disease-related genes prediction. The non-OMIM genes in the network are used as candidate test genes. Table 2 lists the seed genes for breast cancer.
Methods of constructing gene interaction (or association) network (Ozgur et al., 2008; Pujana et al., 2007) can be used to produce more disease-specific network. Obtaining gene association networks is very meaningful for disease genes identification. We anticipate more biological data sources can be integrated for the construction of disease-specific network.
Methods
Figure 1 schematically illustrates our approach. The aim of MCDGPA is to predict potential disease-related genes. We first partition the network into several modules and then obtain the ranking of candidate genes in each disease-associated module, and finally give a global ranking of candidate genes in the entire network to select the most probable disease gene. ENDEAVOUR, DK, and RWR have shown to be effective in previous research (Aerts et al., 2006; Kö hler et al., 2008) . Here we put forward three MCDGPAs: MENDEAVOUR, MRWR, MDK. MCDGPA is composed of three steps: network partition, getting local ranking in each disease-associated module, and getting global ranking in the entire network (The code of the MCDGPA can be downloaded from http:/ /www .aporc.org/doc/wiki/MCDGPA ).
Network partition
First, network is partitioned using the network clustering method based on compressing the information of a random walk taking place in the network (Rosvall and Bergstrom, 2008) . The optimal compression is achieved by optimizing the minimum description length of the random walk by greedy search and simulated annealing. It is difficult for most existing clustering algorithms to automatically determine the number of modules in biological network. The particular advantage of this algorithm is that it can automatically detect the number of modules in the process of simulated annealing. The method has been successfully applied to scientific communication network and can uncover the community structure in the complex network. In the following we will refer to this module partition method as Rosvall's algorithm.
There are two important reasons for using network clustering methods to detect disease-associated modules. One is that the coverage of the gene functional annotation is limited. Only two-thirds of all the genes are annotated by at least one functional annotation ). Additionally, genes that already have functional annotations may still have unidentified functions (Hutz et al., 2008) . Hence, using functional annotation to implement modules partition suffers from annotation bias. More importantly, it is also not evident how the annotated functions of the genes relate to the disease phenotype (Ala et al., 2008) . However, network clustering methods can be implemented in any gene interaction (or association) network. High-throughput genomic work has produced a large amount of relatively unbiased data that include metabolic, regulatory, functional, and physical interactions. Many methods have been devoted to integrating these diverse datasets into a disease-specific network, and hence, have accelerated the use of network clustering method in the disease-related field (Franke et al., 2006; Ozgur et al., 2008; Pujana et al., 2007) . The other reason is that scale-free and small-world properties appear not only in the social networks but also biological networks. Methods for both social and web networks have been successfully used for biological networks. Markov cluster algorithm has been used to large-scale detection and categorization of protein families (Enright et al., 2002) . PageRank algorithm employed by the popular search engine Google has been used to prioritize the candidate disease genes (Morrison et al., 2005) . Recently extended versions of the PageRank, HITS algorithms, and the K-Step Markov method have been . Dense modules from protein interaction networks (DICS) database (Ditemann et al., 2009 ) can be accessed for retrieving sets of overlapping modules that are significantly enriched in a gene list. The module partition result by Rosvall's algorithm and DICS will be compared to further illustrate the reasonability of network partition result. In the supplementary method, a brief introduction of DICS has been given and the consistency measure reflecting the consistency between module partition results from different module partition algorithms has been proposed. The reason of choosing DICS to compare with our module partition result is that the web server of DICS can provide modules that are associated with the disease mutations from the Human Gene mutation database (Stenson et al., 2003) . In MCDGPA, the purpose of module partition is to identify disease-related genes, so it is meaningful to compare the result with a disease-related module partition method. So far there has been no gold standard method in terms of module partition. The comparison is used only to demonstrate the reasonability of our module partition algorithm.
Getting local ranking in each disease-associated module
Second, well-known ENDEAVOUR, RWR, and DK (Aerts et al., 2006; Kö hler et al., 2008 ) are adopted to prioritize the candidate genes in each disease-associated module. We refer to the rank of genes in the module as local ranking comparing to the global ranking, which means the rank of gene in the entire network.
Compared to many previous computational methods utilizing only one or two data sources, ENDEAVOUR (Aerts et al., 2006) integrates the information about human genes and proteins from over 10 publicly available databases and can prioritize candidate genes based on their similarity to seed genes. It first generates distinct prioritization list of candidate genes for each data source and then fuses each of these rankings from the separate data source into a single ranking using order statistics. In addition, ENDEAVOUR has a freely accessible, interactive, and flexible web interface (Tranchevent et al., 2008) .
In contrast to many previous methods that search for direct neighbors of known disease genes or uses the calculation of the shortest path between candidates and known disease proteins, global network distance measures, RWR, and DK, define the global similarity between each node pairs in the network (Kö hler et al., 2008) . The random walk is denoted as an iterative walker's transition from its current node to a randomly selected node starting at a given source node. RWR allows the restart of the walk in every step at source node with probability r. The initial probability was formed such that equal probabilities are assigned to the nodes representing the seed genes, with the sum equal to 1. The diffusion kernel (Kö hler et al., 2008 ) of a network is denoted as
where L is the Laplacian of the network and b controls the magnitude of the diffusion. Based on the matrix K, the score of the candidate gene j is defined as Global ranking in the whole network
The basic idea of MCDGPA is shown. First, we partition the network into several modules; then we obtain the local ranking of nonseed genes in each disease-associated module using ENDEAVOUR, RWR, or DK; finally, the ranking fusion algorithm further gives each gene a global ranking in the entire network to select the most probable disease gene.
We only implement these gene prioritization algorithms in disease-associated modules. For the local ranking in each disease-associated module, we do not select all the known disease genes as training genes. Only the seed genes in that module will be used.
Getting global ranking in the entire network
Finally global ranking of candidate genes is obtained based on the local ranking and module partition result. ENDEAVOUR fused different prioritizations of genes for multiple data sources into a global ranking using order statistics. Here a new algorithm is developed to fuse the local ranking of genes in the disease-associated module into a global ranking in the entire network.
The global rank of the gene is decided by its local rank and the information of the module where it is located. The high rank in the entire network should be given to genes with high local rank in the disease-related module. The information of the module is represented by the number of seed genes in that module and the size of the module. Most people think disease genes deploy their functions as part of sophisticated functional modules (Barabási and Oltvait, 2004; Oti and Brunner, 2007) . Many studies have also shown this type of module-based interpretation of phenotypic effects (Lage et al., 2007; Vanunu et al., 2010; Wang et al., 2008) . So potential disease-related genes will always appear near the known disease genes, and furthermore, the module that has many known disease genes is likely to have more potential disease genes. On the other hand, if two modules with equal number of seed genes, then the bigger module may be more likely to have more potential disease-related genes. Hence the probability that the module has potential disease-related genes is directly proportional to the number of seed genes and the size of the module.
Rank fusion is virtually a recursive algorithm. We decide which gene is ranked nth in the entire network based on the top n À 1 genes. It is assumed that we want to get the top N genes in the entire network. Some definition will be introduced as follow. Denote M as the number of modules, s(j) as the product of the number of seed genes in module j and the size of the module j, i as the number of genes having already obtained their global ranking in the recursive process of rank fusion, m(i,j) as the number of top i genes (global rank) located in the module j after having determined the top i genes in the entire network, p(j) as the probability that module j has unknown disease-related gene, t(i,j) as the expectation of the number of top i genes located in module j, e(i,j) as the expectation of probability that the i þ 1 globally ranked genes comes from module j. Hence, p(j), t(i,j), and e(i,j) can be calculated as follows.
The rank fusion algorithm consists of three steps as follows.
Step 1: the top 1 gene in the module with highest probability that it has unknown disease-related genes is chosen as the top 1 gene in the entire network (i ¼ 1).
Step 2: assuming that we have obtained top i genes in the entire network, now we want to decide the i þ 1 ranked gene. Because e(i,j) indicates the expectation of probability that the i þ 1 globally ranked genes from module j, the i þ 1 globally ranked genes will be from the module with the biggest e(i,j) among the module having the non-ranked (global ranking) genes. Let this module be module Q, so the genes ranked m(i,Q) þ 1 in the module Q will be chosen as the top i þ 1 ranked gene in the entire network (because in the module Q, top m(i,Q) genes has obtained the global ranking).
Set i ¼ i þ 1.
Step 3: repeat step 2 if i is less than N; otherwise, end the algorithm.
Cross-validation
In order to measure the performance of the disease gene prioritization method, we carry out a leave-one-out crossvalidation for the prostate cancer and breast cancer network. Each seed gene is taken in turn as a test dataset and the remaining seed genes are used as training dataset. An enrichment score is calculated to evaluate the performance of the methods. The formula is Enrichment ¼ the number of candidate genes/2/the rank of left out genes. For example, if a prioritization method gives the actual disease genes the highest ranking and the number of candidate genes is 100, then there is an enrichment of 50-fold.
Sensitivity to module partition algorithms
It is very important to know whether the result of MCDGPA is sensitive to the selection of module partition algorithms; hence, another two module partition methods are tried: Markov Cluster Algorithm (MCL; Van Dongen, 2000) and CFinder (Palla et al., 2005) .
MCL is based on probability and graph flow theory. It simulates random walks on a graph using Markov matrices to determine the transition probabilities among nodes of the graph (Van Dongen, 2000) . MCL has been applied to a number of different domains, mostly in bioinformatics. For example, the MCL algorithm has previously been exploited for clustering a large set of protein sequences, where it was found to be very fast and reliable in dealing with complicated domain structures (Enright et al. 2002) .
CFinder (Palla et al., 2005) looks for clusters that may overlap. It was the first algorithm in the network clustering to address this problem, which is important in many systems. The clusters at each time step are extracted using the clique. CFinder is a fast and efficient method for clustering data represented by large network, such as genetic or social networks and microarray data.
Disease-related genes prediction
MCDGPA is used to search for potential disease-related genes. Then methods are evaluated by examining the number of genes that are confirmed to be related with the disease by other databases or literature in the top n ranking of candidate genes (here OMIM genes are used as seed genes). For the evaluation of the performance of the algorithms, the top n curve is drawn (the curve describing the relation between n and the number of confirmed genes in the top n ranking). For MRWR, experiments are also implemented to confirm the improvement on the classical RWR is independent of the selection of back probability. MRWR is tested under nine different test conditions (MRWR with back probability 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9).
Sensitivity to the literature validation
To show the prediction performance is not sensitive to the literature validation, we only consider the validation from databases. In this case, top n curves of modularized algorithm and classical algorithms are also shown to confirm that the improvement is not influenced by discarding the literature validation.
Results
First, MCDGPA is applied to the prostate cancer network to demonstrate that our modularized algorithms can improve the performance in terms of cross-validation and diseaserelated genes prediction.
The result of module partition
Here Rosvall's algorithm is used to partition the prostate cancer network. Table 3 lists the result of module partition. From Figure 2 we can reach the conclusion that known OMIM genes are located in different modules. There are three modules related to prostate cancer in the DICS database containing 20, 7, and 4 genes, respectively. Genes that are located in both our prostate cancer network and modules obtained from DICS are denoted as common genes. It has been illustrated that common genes in the same DICS module are also in the same module of our network. We try to calculate the consistency between the result of our module partition (our module) and modules that are enriched in all the genes in our network by DICS (DICS module). Supplementary Table 1 lists the modules that are enriched in all the genes in the prostate network by DICS. In the supplementary method, we propose the concept of consistency score to compare the module partition result by Rosvall's algorithm and DICS. The final consistency score is 0.8247. We also randomly partition the network into 19 modules (because Rosvall's algorithm has partitioned the network into 19 modules) and calculate the consistency score between module partition result by random and DICS. We repeat 10,000 experiments and get average consistency score 0.16662. A t-test is used to test whether the significant difference exist in the consistency score between random modules and DICS modules and the score between Rosvall's algorithm and DICS modules. The p-value is 9.5121e-271, which shows Rosvall's module partition significantly differs from random result. Here the consistency score is used only to demonstrate the reasonability of our module partition algorithm. Module 1  AR, TP53, BRCA1, EREG, AKT1, TNF, CCND1, MYC, CHEK2, PTEN, BRCA2, APC, NR3C1, PPYR1,  MAPK8, CDKN1B, VEGFA, MDM2, TMEM37, STAT3, SNORA62, IL10, INS, SRC, EGF, CHEK1,  CDKN2A, BCL2, FZR1, SSSCA1, TCEAL1, POLD1, RB1, CNTN2, BAX, FOS, EGFR, SPNS1, CDK4,  TIMP1, PCAF, PSAT1, RAD51, PARP1, ATM, TBP, SERPINA2, EP300, TLR4, HDAC1, NCOA2, TP73,  ATRX, CD40, NR5A1, HDAC2, PTK2, STUB1, RAD17, HSP90AA1, HDAC9, PDPK1, HTATIP, SKP2,  STK11, TIPARP, CP, PLK1, TSC2, FRAP1, RORC, CDC20, ATR, RAD1, LTA, HR, CDK8, HSPB1,  TP53BP1, EPO, RASGRF1, ELAVL1, FAS, MGMT, INSR, OXER1, RLN3, NCL, HDAC3, NRIP1, RAD9A,  TGIF1, RAD51C, IRF7, SNCG, SIN3A, PSMD4, NCOA3, IK, MLH1, MRC1, CORO1A, MYOD1, MT1A,  POU3F1, GTF2H3, H2AFX, MDC1, NEK2, XRCC3, ABL1, JUND, NLRP2, WEE1, BXDC5, LMOD1,  EFNA5, CLEC3B, MSC, AKT2, ILK, MUS81, GLS2, REN, EID3, DDR1, HSPD1, NCOA4, PIAS1, UBE3A,  CTD, CRB2, C2, HEY1, TLR9, ITK, FOLH1, TACC3, RUNX3, EEC1, TFF2, PITX1, RNF14, IKZF1 
Cross-validation
Leave-one-out cross-validation is used in the prostate cancer network and the enrichment is calculated. The enrichment of MCDGPA based on Rosvall's module partition algorithm and classical algorithm without module partition are compared. OMIM genes are used as test dataset, and the enrichment comparison result is shown in Figure 3 , which shows that MCDGPA outperforms previous algorithms without module partition. Because many non-OMIM genes in the network are also related to the prostate cancer, we also use all the genes that are validated by databases [OMIM, Prostate Gene DataBase (PGDB), and KEGG] as enlarged test dataset. Known prostate cancer genes in the enlarged test dataset are shown in Table 4 . Also, the enrichment is calculated and shown in Figure 4 , which still shows MCDGPA outperforms previous algorithms.
Robustness to the module partition algorithms
To confirm that MCDGPA is not sensitive to the selection of module partition, MCDGPA based on another two module partition methods (MCL and CFinder) is evaluated in the cross-validation schema. When CFinder is used to partition the network, the overlapping modules are obtained. The enrichment comparisons based on different module partition methods and different gene prioritization methods in each disease-associated module are shown in Figures 3 and 4  (Fig. 3 shows the results when OMIM genes are used as test dataset; Fig. 4 shows the results when all the genes validated by various databases are used as an enlarged test dataset). The results confirm that the performance improvement is not sensitive to the selection of module partition methods and gene prioritization methods in each disease-associated module.
Disease-related genes prediction
In the prostate cancer network, OMIM genes are used as seed genes and MCDGPA is used to search for new potential disease-related genes. Methods are evaluated by examining the number of genes that are confirmed to be related with the disease by PGDB, KEGG, or literature in the top n ranking of non-seed genes. The result comparison between MCDGPA based on different module partition methods with ENDEAVOUR (Aerts et al., 2006) , DK, and RWR (Kohler et al., 2008 ) is shown (Fig. 5 for MENDEAVOUR, Fig. 6 for MDK, and Fig. 7 for MRWR). The top n curves by MCDGPA are almost everywhere above the curve by corresponding previous algorithms. This further confirms the improvement in the prediction ability. The top 50 ranking genes by MCDGPA based on different module partition methods in the prostate cancer network are listed in Table 5 (for MENDEAVOUR), Table 6 (for MDK), and Table 7 (for MRWR). All the genes inferred by MCDGPA are shown in Table 8 . Here we would like to emphasize that we have presented a general framework that allows integrating many previous similarity methods and can improve them. For MRWR, experiments show that the improvement on the classical RWR is independent of the selection of back probability. MRWR is tested under various back probability values. The top n curves under the nine different test conditions (MRWR based on different module partition algorithms and RWR with back probability 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, and 0.9) are shown in Figure 8 . It is observed that the improvement by MRWR is robust to the choice of back probability.
Sensitivity to the literature validation. To show the prediction performance is not sensitive to the literature validation, we only consider the validation from databases in the prediction of prostate cancer-related genes. In this case, the comparison between top n curves of MCDGPA and classical algorithms is also shown (Fig. 9 for MENDEAVOUR, Fig. 10 for MDK, and Fig. 11 for MRWR). The top n curves by MCDGPA are again better than the curves by corresponding previous algorithms. 
Biological analysis
Ten genes are proposed to have the highest priority for experimental validation (AKT1, ATM, BRCA1, CCND1, CDKN1B, CDKN2A, MDM2, MYC, RB1, and TP53). These genes are not only confirmed by PGDB, KEGG, or the literature, but also ranked in the top 50 by MENDEAVOUR, MDK, and MRWR based on at least two module partition algorithms.
Indeed, these 10 genes are associated with prostate cancer. Prostate cancer develops in the prostate, a gland in the male reproductive system. The normal development and maintenance of prostate is through hormones acting on corresponding receptors. Activated AKT1, which is involved in the regulation of cell growth and survival, phosphorylates many downstream signal molecules (Vara et al., 2004) . Phosphorylated p27, coded by gene CDKN1B, together with inactivated tumor suppressor gene PTEN, is confirmed to be crucially relevant to prostate cancer through the control of cell cycle progression (Chang et al., 2004; Di Cristofano et al., 2001 ). Rb, a downstream molecule of p27, is involved in the tetraploidization of prostate cancer cells because of its role in hindering G1/S progression (Kubota et al., 1995; Li et al.,1998) . MDM2, a p53-stabilizing protein (Buschmann et al., 2000) , is another phosphorylated target of AKT1. Activated MDM2 has a role in prostate cancer via p53-dependent and p53-independent mechanisms where multiple genes are involved . The p53 signaling pathway is frequently related to the development of prostate cancer. It is demonstrated that a pathway of prostate cancer progression involves p53 inactivation caused by MDM2 overexpression (Osman et al., 1999) . In addition to MDM2, many other molecules are involved in this pathway. For example, gene CDKN2A, which codes p16ink and p14ARF, regulates two critical cell cycle regulatory pathways: Rb and TP53. In detail, p16ink is a cyclin-dependent kinase inhibitor, whereas p14ARF binds to MDM2 Sharpless, 2005) . Research indicates that ATM substitution P1054R is a risk factor of prostate cancer development (Angele et al., 2004) . ATM activates DNA repair and checkpoint pathways by phosphorylating multiple targets, for example, TP53, MDM2, and BRCA1. BRCA1 is also involved in cell apoptosis (Langston et al., 1996) . CCND1 A870G polymorphism is associated with increased risk of prostate cancer because Cyclin D1, coded by gene CCND1, plays a key role in cell proliferation. C-MYC is another key signal molecule in the cell cycle. Increased copy number of MYC gene is observed in human prostate cancer (Bubendorf et al., 1999; L.Z. Wang et al., 2003) .
A strong restriction of the experimental validation scope is provided. Six genes are chosen as potential new 1-5 CHEK1,ATR,NR3C1,EP300,RAD51  CDK4,EP300,RAD51C,MDM2,FANCD2 ATR,CHEK1,NR3C1,CDK4,RAD51  6-10 CDK4,MXD1,MDC1,ATM,FANCD2  CHEK1,NCOA3,BRCA1,ATR,NR3C2  EP300,BRCA1,ATM,TP53,RB1  11-15 BRCA1,PLK1,TP53,TP53BP1,CD81  MDC1,ATM,NCOA4,TP53BP1,POLD1 MDM2,NCOA4,TP53BP1,NCOA2,  STK11  16-20 RB1,MDM2,NCOA2,STK11,AKT1  REN,AKT1,STK11,TP53,NEK2  NR5A1,AKT1,NR3C2,RAD17,TBP  21-25 NR5A1,NCOA3,RAD17,TBP, ,RASGRF1 PARP1,ATM,PDPK1,CHEK1,MYC  CHEK1,PARP1,CDKN2A,TNF,  POLD1  11-15 SKP2,POLD1,TIMP1,SSSCA1,MDM2  CDKN2A,TXN,RASGRF1,SKP2,POLD1 MDM2,SKP2,TIMP1,SSSCA1,EREG  16-20 KLF13,SRC,CDKN1B,EREG,RAD17  SSSCA1,MDM2,TIMP1,CDKN1B,SRC CDKN1B,SRC,HSPB1,FAS,LTA  21-25 SERPINA2,RAD1,MYC,TCEAL1,MAX  EREG,CREB1,SUV39H1,ATF1,BMI1  TCEAL1,CDC7,SERPINA2,  TNFSF10,CD40  26-30 RAD9A,TP53BP1,AKT1,RB1,TIPARP  PRC1,HNF1A,NEK2,MXD1,CDH11  MYC,HR,RAD17,BCL2,RHOD  31-35 NLRP2,RAD51,HR,AKT2,ARF6  UBD,PTPRK,NMT1,CDK2AP1,CDC20 RAD1,TP53BP1,TIPARP,  RAD9A,TLR4  36-40 BCL2,VEGFA,BAX,CDK8,PLK1  MAX,APC,LOX,SLC2A3,KLF13  MAPK1,NLRP2,ATR,CNTN2,  AKT1  41-45 SRXN1,FANCD2,NCOA3,CREB1,RORC TCEAL1,SERPINA2,RAD17,HR,RAD1 RB1,BAX,VEGFA,IL1A,IL10  46-50 WEE1,RAD51C,XRCC3,MDC1,CDK2AP1 RAD9A,RAD51,TP53BP1,RB1,NLRP2 PTK2,INS,PPYR1,MMP1,ATRX   346 CHEN ET AL. The number indicates that the times when given gene is ranked within the top 50 by this modularized candidate disease genes prioritization method using different module partition algorithms. disease-related genes (CHEK1, PARP1, POLD1, RAD17, RAD51, and SSSCA1) and need further evidence to confirm their relevance to prostate cancer. These genes are not confirmed by PGDB, KEGG, or the literature but ranked in the top 50 by MENDEAVOUR, MDK, and MRWR based on all three module partition algorithms.
Prioritization of the breast cancer genes
MCDGPA is also applied to the breast cancer network to further demonstrate the improvement of result. Rosvall's module partition algorithm is used to partition the breast cancer network. Table 9 lists the result of module partition. From Figure 12 , we can get conclusion that known OMIM genes are located in the same module.
First, leave-one-out cross-validation is used in the breast cancer network and the enrichment is calculated. The enrichment of MCDGPA based on Rosvall's module partition algorithm and classical algorithm without module partition are compared. OMIM genes are used as test dataset, and the enrichment comparison result based on different gene prioritization methods in each disease-associated module is shown in Figure 13 , which confirms the performance advantage of MCDGPA compared to classical algorithms without module partition.
Second, MCDGPA based on another two module partition methods (MCL and CFinder) is evaluated in the crossvalidation schema to confirm the result of MCDGPA is not sensitive to the selection of module partition. The enrichment comparisons based on different module partition methods and different gene prioritization methods in each diseaseassociated module are shown in Figure 13 . The results confirm that the performance improvement is not sensitive to the selection of module partition methods and gene prioritization methods in each disease-associated module.
Finally, OMIM genes are used as seed genes, and MCDGPA is used to search for new potential disease-related genes. Methods are evaluated by examining the number of genes that are confirmed to be related with the disease by the Tumor Gene family of databases (TGDB) (http:/ /www .tumorgene.org/TGDB/tgdb.html) and literature (Cox et al., 2006; Karppinena et al., 2006; Wu et al., 2000; Zhao et al., 2003) . Six non-seed genes in this network are confirmed to be associated with breast cancer by TGDB and the literature, so we only need to obtain ranks of these genes in the prioritization by each algorithm. Results are shown in Tables 10, 11 For MRWR, experiments are also implemented to confirm the improvement on the classical RWR is not independent of the selection of back probability. MRWR is tested under different back probability values. The top n curves under the nine different test conditions (MRWR based on different module partition algorithms and RWR with back probability 0. 1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9) are shown. It is observed that the performance of MRWR is robust to the back probability.
and 12 based on different gene prioritization methods in each disease-associated module. It is observed that confirmed genes almost obtain better ranks by MCDGPA than classical algorithm. The validation shows that even if known seed genes are located in the same module, MCDGPA is still superior to previous algorithms in term of both crossvalidation and disease-related genes prediction. Table 13,   Table 14, and Table 15 list top 50 ranking genes by MENDEAVOUR, MDK, and MRWR in the breast cancer network.
Six genes are proposed to have the highest priority for experimental validation (AURKA, MSH2, RAD51C, RB1, TOP1, and TOPBP1). These genes are not only confirmed by PGDB, KEGG, or the literature, but also ranked in the top 50 by MENDEAVOUR, MDK, and MRWR based on at least two module partition algorithms.
The relationship between proposed genes and breast cancer is elucidated as follows. Research indicates that the retinoblastoma (RB) tumor-suppressor gene is associated with breast cancer (Berns et al., 1995) . Deregulation of RB1 gene promotes breast tumor's aggressiveness and rapid tumor cell proliferation through inactivation of the cyclindependent kinase inhibitor 2A (CDKN2A) (Chin et al., 2004) . Gene MSH2 functions during the process of mismatch repair. Test of loss of heterozygosity for tumors found loss of the wild-type MSH2 allele (Yee et al., 1994) in breast cancer samples. AURKA is an important protein in the regulation of G2/M transition. It is shown that AURKA has been identified as a low penetrance breast cancer susceptibility gene (Cox et al., 2006) . The chromosomal region 17q23 was discovered to be amplified in the breast tumor. Copy number analysis indicates that RAD51C is relevant to breast cancer (Wu et al., 2000) . TopBP1 (topoisomerase IIbeta binding protein 1) displays sequence homology and functional similarities with BRCA1, a strong candidate for the breast cancer (Miki et al., 1994) . TopBP1 Arg309Cys is a commonly occurring alteration possibly associated with a slightly increased breast cancer risk (Karppinena et al., 2006) . Over expression of NCOA3 is correlated with the absence of estrogen and progesterone receptors, which are both prognostic factors of breast cancer (Bouras et al., 2001) . Elevated expression level of NCOA3 is associated with shorter To show the prediction performance is not sensitive to the literature validation, we only consider the validation from databases in the prediction of prostate cancer-related genes. In this case, the comparison between top n curves of MRWR and RWR is shown. The top n curve by MRWR is still almost everywhere above the curve by RWR, confirming the improvement is not influenced by discarding the literature validation. Module 1  BRCA1,RAD51C,BRCA2,TOP1,TOP2A,BLM,CHEK2,RPA1,RB1,CSNK2A1,TIMELESS,ATM,RECQL,PPP1CC,  MRE11A,CCNA2,SNRPA,RRM1,ASF1A,MSH2,PRKDC,PRPF4,DUT,MCM4,TFDP1,RAD54L,BUB3,AURKA,  SMC4,NFYB,MYBL2,SNRPA1,RQCD1,CNOT3,RAD51AP1,DDX46,STAT5A,UNG,TMPO,DDX39,BAT1,  DNMT1,RBBP8,TFDP2,TTF2,NASP,GINS1,NAE1,PSIP1,EZH2,PRPS1,RAD1,FANCI,DNJC9,TBCA,TOPBP1,  H2AFV  Module disease-free and overall survival in patients with breast tumors . A typical example to show the efficiency of our method is the predicted disease gene BLM. We note that BLM is not confirmed by TGDB, although it is ranked in the top three by MENDEAVOUR, MDK, and MRWR based on all the three module partition algorithms. Even MDK ranks the gene BLM first based on all the three module partition algorithms. However, one recent research work confirmed the close association between BLM and breast cancer (Ding et al., 2009) by finding that one single nucleotide polymorphism (SNP) (rs2380165) in BLM is shown to be associated with breast cancer risk based on the case-control study. The breast cancer network is generated before the publication of this article; hence, this independent literature validation AURKA  10  8  9  9  MSH2  1  1  1  1  RAD51C  39  26  30  31  RB1  13  9  13  12  TOP1  35  18  27  27  TOPBP1  9  7  8 No ranking
Six nontraining genes in this network are confirmed to be associated with breast cancer, so we only need to obtain ranks of these genes in the prioritization by ENDEAVOUR and MENDEAVOUR. Confirmed genes almost obtain better ranks by MENDEAVOUR. The validation again gives a strong support to the superiority of MCDGPAs to previous algorithms. AURKA  35  21  28  30  MSH2  12  9  10  12  RAD51C  8  5  5  8  RB1  24  18  19  21  TOP1  7  6  6  5  TOPBP1  55  40  40  No ranking Six nontraining genes in this network are confirmed to be associated with breast cancer, so we only need to obtain ranks of these genes in the prioritization by DK and MDK. Confirmed genes almost obtain better ranks by MDK. The validation again gives a strong support to the superiority of MCDGPAs to previous algorithms. AURKA  35  24  28  39  MSH2  12  11  10  28  RAD51C  8  4  5  4  RB1  24  9  19  23  TOP1  7  2  6  6  TOPBP1  55  43  40  No ranking Six nontraining genes in this network are confirmed to be associated with breast cancer, so we only need to obtain ranks of these genes in the prioritization by RWR and MRWR confirmed genes almost obtain better ranks by MRWR. The validation again gives a strong support to the superiority of MCDGPAs to previous algorithms. 1-5  MSH2,BLM,MRE11A,PRKDC,CCNA2  MSH2,BLM,MRE11A,PRKDC,RBBP8  MSH2,MRE11A,BLM,PRKDC,  RBBP8  6-10 RBBP8,TOPBP1,AURKA,RB1,MYBL2  CCNA2,CDC2,TOPBP1,AURKA,MCM2 CCNA2,SMC1A,CDC2,AURKA,  MCM2  11-15 RAD1,RECQL,RAD51AP1,TFDP1,RPA1 CDC20,CDC7,RB1,RAD1,MYBL2  CDC7,RB1,CDC20,POLE,SMC3  16-20 EZH2,MCM4,TOP1,PPP1CC,TFDP2  RECQL,NDC80,MCM5,RAD51AP1,  RPA1   RECQL,RFC4,MYBL2,NDC80,  TFDP1  21-25 TTF2,KIAA1794,NFYB,APPBP1,UNG  TFDP1,MCM6,MCM4,FANCI,TTF2  RPA1,RAD51AP1,MCM5,  MCM6,RAD21  26-30 RAD51C,TIMELESS,DUT,DNMT1,RRM1 SUZ12,TOP1,TFDP2,CHAF1A,RAD51C PCNA,TOP1,MCM4,PPP1CC,  UNG  31-35 GINS1,STAT5A,H2AFV,DDX39,ASF1A UNG,SKP2,NAE1,RBBP4, ,TOP2A  11-15 MRE11A,DUT,RPA1,PPP1CC,ASF1A  RAD51AP1,CSNK2A1,MRE11A,  DUT,RPA1   RAD51AP1,MSH2,RAD21,  SMC1A,MRE11A  16-20 PSIP1,RBBP8,RB1,BUB3,UNG  PSIP1,ASF1A,RBBP8,RB1,BUB3  DUT,CSNK2A1,PCNA,  RPA1,PPP1CC  21-25 AURKA,TTF2,STAT5A,GINS1,NASP  UNG,STAT5A,GINS1,NASP,TTF2  RB1,RBBP8,ASF1A,  UNG,NDC80  26-30 RECQL,TIMELESS,RRM1,RAD1,FANCI NDC80,MCM6,AURKA,RECQL,RRM1 RFC3,POLE,BUB3,MCM6,  AURKA  31-35 DNJC9,SNRPA,NFYB,SMC4,MYBL2  DNJC9,FANCI,RAD1,SNRPA,NFYB  RECQL,POLA1,TIMELESS,  RRM1,SMC3  36-40 TFDP2,NAE1,EZH2,H2AFV,TOPBP1  DNA2,MCM5,MYBL2,SMC4,TOPBP1  AATF,SNRPA,NFYB,DNA2,  SMC2  41-45 MCM4,DDX39,BAT1,CNOT3,PRPF4  TFDP2,H2AFV,HMMR,NAE1,RBBP4  MCM5,SMC4,MYBL2,KIFC1,  MAD2L1  46-50 TBCA,DDX46,PRPS1,TMPO,DNMT1  TCERG1,KIFC1,CDC20,MAD2L1,  MCM2 CDC20,MCM4,MCM2,LMNB1, IDH3B PSIP1,ASF1A,RBBP8,RB1,BUB3  CSNK2A1,MCM6,TIMELESS,  RFC3,RRM1  21-25 PSIP1,NFYB,RBBP8,AURKA,BUB3  UNG,STAT5A,GINS1,NASP,TTF2  MCM5,CCNA2,RB1,PRKDC,  MCM4  26-30 UNG,PRPF4,MYBL2,GINS1,NASP  NDC80,MCM6,AURKA,RECQL,RRM1 CDC20,TFDP1,MSH2,MCM2,  SMC1A  31-35 STAT5A,TTF2,SMC4,MCM4,CNOT3 DNJC9,FANCI,RAD1,SNRPA,NFYB  SNRPA,PPP1CC,NDC80,  MRE11A,ASF1A  36-40 TFDP2,DNJC9,FANCI,RAD1,BAT1  DNA2,MCM5,MYBL2,SMC4,TOPBP1 LMNB1,DUT,NFYB,AURKA,BUB3  41-45 DDX39,DDX46,EZH2,H2AFV,NAE1 TFDP2,H2AFV,HMMR,NAE1,RBBP4  SMC4,PPP2R5C,AATF,  IDH3B,DNA2  46-50 TOPBP1,RQCD1,SNRPA1,PRPS1,  TBCA   TCERG1,KIFC1,CDC20,MAD2L1,  MCM2 XPO1,MYBL2,RQCD1, SMC3,RAD51AP1
further demonstrates that the computational identification of BLM is meaningful and gives a strong support to the performance of our modularized methods.
Discussions and Conclusion
We have recently witnessed the emergence of similaritybased methods for prioritization of probable disease genes. Finding modules associated with disease can help the understanding of disease mechanism, the identification of disease genes, and the classification of disease. Module-based interpretation of phenotypic effects is very important and meaningful in disease mechanism research. We have developed a modularized candidate disease gene prioritization algorithm (MCDGPA) to map associations between cancer and cancer-related genes. MCDGPA is based on the hypothesis that discovering new potential disease-related genes in the disease-associated modules and using only the seed genes that are located in the same module with the candidate genes would benefit the performance of prediction. The algorithm is divided into three steps: module partition, genes prioritization in each disease-associated module, and rank fusion to obtain the global ranking.
We demonstrate that MCDGPA is superior to previous similarity-based methods. In the prostate cancer network, disease-related genes are located in different modules. MCDGPA outperforms traditional algorithms in the prediction performance not only when we try different gene prioritization methods in the process of prioritization in the each module, but also when we use different module partition algorithms to partition the network. In terms of crossvalidation and prediction when the validation from literature is excluded, MCDGPA still improves previous algorithms. For the breast cancer network, the known seed genes are located in the same module. In this case, MCDGPA also can get the improvement on classical algorithms.
We conclude that similarity-based algorithm after being processed by network partition, gene prioritization per module, and rank fusion can get much better result than previous algorithms. Hence, MCDGPA is a framework that allows integrating many previous gene prioritization methods and may outperform the results of them. We suggest that MRWR, MENDEAVOUR, and MDK should be applied to other disease-specific networks to obtain valuable candidates disease genes for medical improvement. The success of our method can be attributed to a combination of several factors. First, we make use of the information of disease-specific networks instead of searching for disease-related genes in the whole genome. In this case, the establishment of the association between the network and the disease narrows down the scope of searching for disease-related genes. Also, we partition the network into several modules and find the modules associated to the disease. The module-based interpretation of disease mechanism benefits the performance improvement. Finally, we search for the potential disease-related genes near the known OMIM genes. In this case, the scope of search is narrowed down, and hence the performance is improved. In a word, the improvement of results compared to classical algorithms is attributed to the idea of modularization. Our article gives a strong support to the module-based interpretation of disease mechanism.
If more known disease genes can be obtained, MCDGPA will be further improved by excluding the modules that do not have any known disease gene. The effectiveness of MCDGPA strongly depends on the construction of a diseasespecific network. If the network integrating more data sources can be obtained, the results will be even better. Biological information can be converted to the weight of vertices and edges in the network. Also, converting the local ranking in the each module into global ranking in the entire network is an interesting and very meaningful problem. In future research we seek to solve this problem using statistics similar to order statistics used in the ENDEAVOUR. In the framework of MCDGPA, many novel gene prioritization algorithms can be developed. These algorithms will benefit the research of disease mechanism and human medicine.
